Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

A...phase 3 study of the oral FXIa inhibitor asundexian (BAY 2433334) for the prevention of ischemic stroke in male and female participants aged 18 years and older after an acute non-cardioembolic ischemic stroke or high-risk TIA (IRB 275367)


Collapse Overview 
Collapse sponsor award id
20604 – 14049


Collapse Biography 

Collapse Time 
Collapse start date
2023-06-16

Collapse end date
2033-06-15